To the full analysis
Buyback calculator for Amphastar Pharmaceuticals
Amphastar Pharmaceuticals stock: key metrics
AMPHAmphastar Pharmaceuticals had an operating margin of 19.5% and a return on invested capital (ROIC) of 9.6% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2011 | 23.7% | −28.3% | 6.5% |
| 2012 | 44.2% | 12.4% | 8.9% |
| 2013 | 37.9% | 7.6% | 5.2% |
| 2014 | 24.4% | −8.5% | −5.1% |
| 2015 | 30.8% | −2.7% | −1.1% |
| 2016 | 40.8% | 6.1% | 4.1% |
| 2017 | 37.8% | −0.4% | 1.9% |
| 2018 | 36.3% | −2.9% | −1.9% |
| 2019 | 40.9% | 0.0% | 15.2% |
| 2020 | 41.0% | 3.1% | 0.4% |
| 2021 | 45.6% | 16.0% | 14.2% |
| 2022 | 49.9% | 21.5% | 18.3% |
| 2023 | 54.5% | 30.6% | 21.3% |
| 2024 | 51.1% | 28.1% | 21.8% |
| 2025 | 49.5% | 19.5% | 13.6% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2011 | 0.0% | no data | 0.0% |
| 2012 | 7.8% | 8.0% | 5.7% |
| 2013 | 4.7% | 5.3% | 3.5% |
| 2014 | −3.8% | −5.8% | −2.7% |
| 2015 | −0.9% | −2.1% | −0.7% |
| 2016 | 3.2% | 3.9% | 2.5% |
| 2017 | 1.3% | −0.3% | 1.0% |
| 2018 | −1.7% | −2.1% | −1.1% |
| 2019 | 12.8% | 0.0% | 8.3% |
| 2020 | 0.3% | 1.3% | 0.2% |
| 2021 | 13.9% | 12.8% | 9.2% |
| 2022 | 17.3% | 19.7% | 12.3% |
| 2023 | 21.5% | 21.9% | 9.1% |
| 2024 | 21.8% | 16.0% | 10.1% |
| 2025 | 12.4% | 9.6% | 6.0% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 4 Sep 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.